Becton Dickinson Valuation Multiples

Becton Dickinson Overview

About Becton Dickinson

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.

Founded

1906

HQ

Employees

72.0K

Website

bd.com

Sectors

Medical Supplies

Financials (LTM)

Revenue: $21B

EBITDA: $6B

EV

$69B

Valuation Multiples

Multiples.vc

Start free trial

Becton Dickinson Financials

Becton Dickinson reported last 12-month revenue of $21B and EBITDA of $6B.

In the same LTM period, Becton Dickinson generated $11B in gross profit, $6B in EBITDA, and $4B in net income.

Becton Dickinson P&L

In the most recent fiscal year, Becton Dickinson reported revenue of $22B and EBITDA of $6B.

Becton Dickinson expects next 12-month revenue of XXX and NTM EBITDA of XXX

Becton Dickinson Stock Performance

Becton Dickinson has current market cap of $50B, and enterprise value of $69B.

Becton Dickinson's stock price is $176.54.

Becton Dickinson Valuation Multiples

Becton Dickinson trades at 3.3x EV/Revenue multiple, and 11.5x EV/EBITDA.

Becton Dickinson Financial Valuation Multiples

As of March 18, 2026, Becton Dickinson has market cap of $50B and EV of $69B.

Equity research analysts estimate Becton Dickinson's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Becton Dickinson has a P/E ratio of 13.0x.

Becton Dickinson Margins & Growth Rates

Becton Dickinson's revenue in the last 12 month declined by (6%).

Becton Dickinson's revenue per employee in the last FY averaged $0.3M.

Becton Dickinson's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Becton Dickinson's rule of X is 15% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Becton Dickinson Public Comps

See public comps and valuation multiples for other Medical Supplies comps.

Becton Dickinson M&A Activity

Becton Dickinson acquired XXX companies to date.

Last acquisition by Becton Dickinson was on XXXXXXXX, XXXXX. Becton Dickinson acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Becton Dickinson Investment Activity

Becton Dickinson invested in XXX companies to date.

Becton Dickinson made its latest investment on XXXXXXXX, XXXXX. Becton Dickinson invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).